Pharmacokinetics of terbutaline after parenteral administration. 1984

P O Fagerström

The basal model-independent pharmacokinetic parameters body clearance (CL), renal clearance (CLR), mean residence time (MRT), and volume of distribution in steady state (Vss) were calculated from concentrations of terbutaline in plasma and amounts in urine after intravenous administration of the drug in 19 healthy men. The data used were from three separate studies. Measurements up to 12 h gave estimated values for CL from 136 mL/min to 340 mL/min, for CLR from 82 mL/min to 192 mL/min, for MRT from 1.5 h to 5.6 h, and for Vss from 24 L to 73 L. In 6 subjects, there were measurements for longer than 24 h that could be used to calculate the parameters. Body clearance was now found to vary between 165 and 270 mL/min. MRT between 7.3 and 11.7 h, and Vss between 83 and 140 L. The evaluations indicate that CL will be overestimated and MRT and Vss underestimated from data only up to 12 h.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003201 Computers Programmable electronic devices designed to accept data, perform prescribed mathematical and logical operations at high speed, and display the results of these operations. Calculators, Programmable,Computer Hardware,Computers, Digital,Hardware, Computer,Calculator, Programmable,Computer,Computer, Digital,Digital Computer,Digital Computers,Programmable Calculator,Programmable Calculators
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013726 Terbutaline A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. Arubendol,Asthmoprotect,Brethaire,Brethine,Bricanyl,Bricanyl SA,Butaliret,Butalitab,Contimit,KWD-2019,Monovent,Taziken,Tedipulmo,Terbasmin,Terbul,Terbutalin AL,Terbutalin Stada,Terbutalin-ratiopharm,Terbutaline Sulfate,Terbuturmant,terbutalin von ct,KWD 2019,KWD2019,Terbutalin ratiopharm

Related Publications

P O Fagerström
January 1984, European journal of respiratory diseases. Supplement,
P O Fagerström
April 1979, International journal of clinical pharmacology and biopharmacy,
P O Fagerström
February 1997, The Journal of family practice,
P O Fagerström
September 1987, Antimicrobial agents and chemotherapy,
P O Fagerström
March 1985, Antimicrobial agents and chemotherapy,
P O Fagerström
January 1987, European journal of clinical pharmacology,
P O Fagerström
February 1996, Journal of veterinary pharmacology and therapeutics,
P O Fagerström
April 1994, American journal of obstetrics and gynecology,
P O Fagerström
October 1990, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!